NRAS G12A

Clinical trials for NRAS G12A explained in plain language.

Never miss a new study

Get alerted when new NRAS G12A trials appear

Sign up with your email to follow new studies for NRAS G12A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for pancreatic cancer patients: experimental immunotherapy offered outside clinical trial

Disease control AVAILABLE

This program provides access to an experimental immunotherapy called ELI-002 7P for patients with a specific type of pancreatic cancer (with KRAS or NRAS mutations) who are at high risk of the cancer coming back after surgery. It is for patients who have no other good treatment o…

Matched conditions: NRAS G12A

Sponsor: Elicio Therapeutics • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

NRAS G12A

Get alerted when new NRAS G12A trials appear

New hope for pancreatic cancer patients: experimental immunotherapy offered outside clinical trial